oral lichen planus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Be capable of giving informed consent and signing the informed consent form;2. Age over 18 years old (including the critical value); 3. Erosive OLP that was diagnosed clinically and histopathologically and met the diagnostic criteria of WHO 2003; 4. Erosion/ulcerative damage occurs on the oral mucosa and the affected area is >=5mm ^2.
Exclusion criteria
Exclusion criteria: 1. Suffering from uncontrolled hypertension, heart disease, diabetes or other systemic diseases; 2. Accompanied by other oral mucosal diseases; 3. Received immunotherapy within 3 months or received local or systemic treatment of OLP within 1 week; 4. Those who have been clearly diagnosed with drug-induced lichenoid damage; 5. Patients suspected of having contact lichenoid lesions; 6. Patients with oral lichenoid damage related to tumors, including those with oral lichenoid damage induced by radiotherapy, chemotherapy, etc; 7. Pregnant or lactating patients; 8. People allergic to triamcinolone acetonide and methylene blue.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficiency rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Apparent efficiency rate;Recovery rate;Visual analogue scale scale;Oral Health Impact Profile scale;The degree of impact on oral health;Subjective discomfort level; | — |
Countries
China
Contacts
The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine